DEFA14A: ORIC Pharmaceuticals Sets Date for Annual Stockholders Meeting

ORIC Pharmaceuticals will hold its annual meeting of stockholders on June 12, 2024, to elect directors and ratify the appointment of KPMG LLP as its independent accounting firm.

Summary

• ORIC Pharmaceuticals will hold its Annual Meeting of Stockholders on June 12, 2024.
• The meeting will be held via live webcast.
• Stockholders of record as of April 17, 2024, are eligible to vote.
• The agenda includes the election of Richard Heyman and Lori Kunkel as directors.
• The agenda includes the ratification of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
• Stockholders can access proxy materials and vote online at www.proxydocs.com/ORIC or www.investorelections.com/ORIC.
• Paper copies of proxy materials can be requested until May 31, 2024.

Sentiment

Score: 5

Explanation: The document is a neutral announcement of the annual meeting and standard proxy voting procedures.

Positives

• The annual meeting provides an opportunity for stockholders to participate in key decisions.
• The availability of a live webcast enhances accessibility for stockholders.

Future Outlook

The document outlines the procedural steps for the upcoming annual meeting, focusing on governance matters.

Industry Context

This announcement is standard practice for publicly traded companies to ensure shareholder participation in corporate governance.

Stakeholder Impact

• Shareholders have the opportunity to vote on key proposals.
• The outcome of the votes will influence the company's governance and financial oversight.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• The company will hold the Annual Meeting on June 12, 2024.

Key Dates

Keywords

Annual Meeting, Stockholders, Proxy Statement, ORIC Pharmaceuticals, Election of Directors, KPMG, Ratification, Voting